Delivery Order SPE2DB20D2104-SPE2DB25FMVVY
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 180 units of JANUMET 50-1,000 MG TABLET. The potential value of the order is $1,733.21, with a completion date of February 26, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not subject to any set-aside designation. The award is part of a larger indefinite delivery contract (IDC) between...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, for the supply of Janumet 50-1,000 mg tablets. The firm-fixed-price contract has a ceiling value of $2,546.79 and a period of performance through June 13, 2024. This delivery order falls under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a maximum value of $999,999,999.00 and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of JANUMET 50-1,000 MG TABLET 180S. The contract has a ceiling value of $10,560.11 and a period of performance through April 3, 2024. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is part of an indefinite delivery contract (IDC) valued at up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of JANUMET 50-1,000 mg tablets. The contract is a firm-fixed price delivery order with a ceiling value of $21,729.58 and a completion date of July 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of JANUMET 50-1,000 mg tablets. The contract has a ceiling value of $1,006.03 and runs through November 25, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets. The contract has a ceiling value of $38,102.96 and is a firm fixed-price delivery order, with a period of performance through September 6, 2024. The contract does not have any set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, will provide the requested prescription medication to support military treatment...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $3,184.24 with a completion date of December 24, 2024. The contract was awarded by the Defense Logistics Agency (DLA) and is for the supply of JANUMET 50-1,000 mg tablets. Amerisourcebergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $23,789.33 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product JANUMET 50-1,000 MG TABLET 180S. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Janumet 50-1,000 mg tablets in 180-count packages, with a ceiling value of $2,030.27 and a performance period through March 28, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical and medical supplies distributor, for the provision of JANUMET 50-1,000 MG tablets. The order, valued at $3,686.26, has a completion date of February 29, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMVVYDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Janumet 50-1,000 mg tablets (180 count) with a ceiling value of $1,224.07. This is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, and was competitively awarded without set-aside provisions. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. As a critical pharmaceutical distributor supporting federal military and veteran healthcare systems, AmerisourceBergen utilizes this comprehensive contract vehicle to supply a broad spectrum of medications, vaccines, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. The pharmaceutical product delivery reflects the company's ongoing role as a prime vendor in the DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 7/18/25 |